Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Details about COVID-19, monkeypox, and the flu vaccine

CLINICAL TRIALS
About Clinical Trials Find a Clinical Trial
CLINICAL TRIALS
About Clinical Trials Find a Clinical Trial

Insulin Resistance in Patients With Major Depression

Trial ID or NCT#

NCT01106313

Status

not recruiting iconNOT RECRUITING

Purpose

The purpose of this study is to study the relationship between insulin and glucose action and neuropsychological functioning (memory, attention, general thinking abilities) in persons with depression.

Official Title

Insulin Resistance in Patients With Major Depression

Eligibility Criteria

Ages Eligible for Study: 20 Years to 65 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Natalie L. Rasgon
Natalie L. Rasgon
Psychiatrist
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult) at the Stanford University Medical Center, Emerita

Contact us to find out if this trial is right for you.

CONTACT

Norma Costello
(650) 736-2182

SEND MESSAGE

View on ClinicalTrials.gov